Company Profile
Aquestive Therapeutics Stock Price, News & Analysis
- Ticker:
- AQST
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Aquestive Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
5.03 USD (+6.57%)
Close
Last updated: June 23, 2026 at 00:00
631.01M USD
Market cap
Why the stock is moving
AQST is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Aquestive Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Aquestive Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Aquestive Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Aquestive Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Source: Aquestive Therapeutics
- 02
Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree
Source: Aquestive Therapeutics
- 03
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
Source: Aquestive Therapeutics
- 04
- 05
Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
Source: Aquestive Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Aquestive Therapeutics (AQST)?
Aquestive Therapeutics (AQST) most recently closed at 5.03 USD, a +6.57% move versus the previous session.
What is the market cap of Aquestive Therapeutics (AQST)?
Aquestive Therapeutics currently has a market capitalization of 631.01M USD on BioPharmSignal.
What does Aquestive Therapeutics do?
Aquestive Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is AQST stock listed?
Aquestive Therapeutics (AQST) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Aquestive Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Aquestive?
Aquestive Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Aquestive Therapeutics targeting with Aquestive?
Aquestive Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Aquestive Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.